Impact of Anxiety on the Decision-making Processes of Anesthesiologists
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · May 3, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how anxiety affects the decision-making of anesthesiologists when choosing methods for giving patients anesthesia, especially in situations where there's uncertainty about risks. The researchers want to understand how different levels of anxiety and impulsivity might influence these important decisions. To gather information, anesthesiologists in the Bourgogne Franche-Comté and Grand Est regions of France will be invited to complete an anonymous online survey.
Eligible participants include anesthesiologists who have completed their PhD and are currently working in either public or private healthcare facilities in France. Unfortunately, residents or retired anesthesiologists cannot participate. By joining this study, participants can contribute to a better understanding of how emotional factors like anxiety can impact clinical choices, ultimately helping improve patient care in anesthesia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all anesthesiologists who have completed their PhD
- • working in France
- • in a public or private healthcare facility
- Exclusion Criteria:
- • residents
- • retired anesthesiologists
About Centre Hospitalier Universitaire De Besancon
The Centre Hospitalier Universitaire de Besançon (CHU de Besançon) is a leading academic medical center located in Besançon, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Besançon focuses on a wide range of medical disciplines, fostering collaboration between healthcare professionals and researchers to develop new therapeutic strategies and improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the institution plays a vital role in translating research findings into practical applications, ultimately enhancing the quality of care provided to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Besançon, Doubs, France
Patients applied
Trial Officials
David FERREIRA, PH
Principal Investigator
Centre Hospitalier Universitaire de Besancon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials